About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: September 2019
Enforcement Update – FDA OPDP Sends Two More Letters
For those who like to keep up on the activity of the Office of Prescription Drug Promotion (OPDP) here is an update. While not shaping up to be another big year of enforcement, there has been a bit of activity … Continue reading
Posted in Warning Letters
Comments Off on Enforcement Update – FDA OPDP Sends Two More Letters
FDA OPDP Research – A Foggy Window into Future Thinking on Digital Media
When one thinks of FDA’s Office of Prescription Drug Promotion (OPDP) there is a likely tendency to think of the regulatory action letters – Warning Letters or Untitled Letters -issued by that office to pharmaceutical companies about their promotional communications. … Continue reading
Posted in New and Social Media
Tagged Digital Health, FDA, Social Media
Comments Off on FDA OPDP Research – A Foggy Window into Future Thinking on Digital Media